2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric SHP2 inhibitors
The present disclosure is directed to inhibitors of SHP2 and their use in the treatment of disease. Also disclosed are pharmaceutical compositions comprising the same.
Gespeichert in:
Hauptverfasser: | , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | BUCKL, ANDREAS KOLTUN, ELENA MELLEM, KEVIN GILL, ADRIAN AAY, NAING JOGALEKAR, ASH KISS, GERT SEMKO, CHRIS WON, WALTER |
description | The present disclosure is directed to inhibitors of SHP2 and their use in the treatment of disease. Also disclosed are pharmaceutical compositions comprising the same. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_TW201808931A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>TW201808931A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_TW201808931A3</originalsourceid><addsrcrecordid>eNrjZMgz0jHVTcksLk0qLsksKS1JTVEw1s1NLcmozFEoqCxKrMrMSy1WSMxLUQAq1DHTLSkiqBaIcnLyi0tSizKTFYI9AowUMvMyMpMyS_KLinkYWNMSc4pTeaE0N4Oim2uIs4duakF-fGpxQWJyal5qSXxIuJGBoYWBhaWxoaMxMWoA85NBiA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric SHP2 inhibitors</title><source>esp@cenet</source><creator>BUCKL, ANDREAS ; KOLTUN, ELENA ; MELLEM, KEVIN ; GILL, ADRIAN ; AAY, NAING ; JOGALEKAR, ASH ; KISS, GERT ; SEMKO, CHRIS ; WON, WALTER</creator><creatorcontrib>BUCKL, ANDREAS ; KOLTUN, ELENA ; MELLEM, KEVIN ; GILL, ADRIAN ; AAY, NAING ; JOGALEKAR, ASH ; KISS, GERT ; SEMKO, CHRIS ; WON, WALTER</creatorcontrib><description>The present disclosure is directed to inhibitors of SHP2 and their use in the treatment of disease. Also disclosed are pharmaceutical compositions comprising the same.</description><language>chi ; eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2018</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180316&DB=EPODOC&CC=TW&NR=201808931A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,778,883,25547,76298</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180316&DB=EPODOC&CC=TW&NR=201808931A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BUCKL, ANDREAS</creatorcontrib><creatorcontrib>KOLTUN, ELENA</creatorcontrib><creatorcontrib>MELLEM, KEVIN</creatorcontrib><creatorcontrib>GILL, ADRIAN</creatorcontrib><creatorcontrib>AAY, NAING</creatorcontrib><creatorcontrib>JOGALEKAR, ASH</creatorcontrib><creatorcontrib>KISS, GERT</creatorcontrib><creatorcontrib>SEMKO, CHRIS</creatorcontrib><creatorcontrib>WON, WALTER</creatorcontrib><title>2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric SHP2 inhibitors</title><description>The present disclosure is directed to inhibitors of SHP2 and their use in the treatment of disease. Also disclosed are pharmaceutical compositions comprising the same.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2018</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZMgz0jHVTcksLk0qLsksKS1JTVEw1s1NLcmozFEoqCxKrMrMSy1WSMxLUQAq1DHTLSkiqBaIcnLyi0tSizKTFYI9AowUMvMyMpMyS_KLinkYWNMSc4pTeaE0N4Oim2uIs4duakF-fGpxQWJyal5qSXxIuJGBoYWBhaWxoaMxMWoA85NBiA</recordid><startdate>20180316</startdate><enddate>20180316</enddate><creator>BUCKL, ANDREAS</creator><creator>KOLTUN, ELENA</creator><creator>MELLEM, KEVIN</creator><creator>GILL, ADRIAN</creator><creator>AAY, NAING</creator><creator>JOGALEKAR, ASH</creator><creator>KISS, GERT</creator><creator>SEMKO, CHRIS</creator><creator>WON, WALTER</creator><scope>EVB</scope></search><sort><creationdate>20180316</creationdate><title>2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric SHP2 inhibitors</title><author>BUCKL, ANDREAS ; KOLTUN, ELENA ; MELLEM, KEVIN ; GILL, ADRIAN ; AAY, NAING ; JOGALEKAR, ASH ; KISS, GERT ; SEMKO, CHRIS ; WON, WALTER</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_TW201808931A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2018</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>BUCKL, ANDREAS</creatorcontrib><creatorcontrib>KOLTUN, ELENA</creatorcontrib><creatorcontrib>MELLEM, KEVIN</creatorcontrib><creatorcontrib>GILL, ADRIAN</creatorcontrib><creatorcontrib>AAY, NAING</creatorcontrib><creatorcontrib>JOGALEKAR, ASH</creatorcontrib><creatorcontrib>KISS, GERT</creatorcontrib><creatorcontrib>SEMKO, CHRIS</creatorcontrib><creatorcontrib>WON, WALTER</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BUCKL, ANDREAS</au><au>KOLTUN, ELENA</au><au>MELLEM, KEVIN</au><au>GILL, ADRIAN</au><au>AAY, NAING</au><au>JOGALEKAR, ASH</au><au>KISS, GERT</au><au>SEMKO, CHRIS</au><au>WON, WALTER</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric SHP2 inhibitors</title><date>2018-03-16</date><risdate>2018</risdate><abstract>The present disclosure is directed to inhibitors of SHP2 and their use in the treatment of disease. Also disclosed are pharmaceutical compositions comprising the same.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | chi ; eng |
recordid | cdi_epo_espacenet_TW201808931A |
source | esp@cenet |
subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | 2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric SHP2 inhibitors |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T06%3A53%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BUCKL,%20ANDREAS&rft.date=2018-03-16&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ETW201808931A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |